Dermatology

Key Takeaways

• Study data show 60% of patients achieved full or partial lesion clearance with bimiralisib gel.
• Efficacy was highest in the four-week treatment group (70% clearance).
• The researchers reported a favorable safety profile with mild, transient adverse events.

Newly presented interim results from a phase 2 clinical trial evaluating bimiralisib topical gel (2%) saw more than half of patients with actinic keratosis achieving complete or partial lesion clearan...

Key Takeaways

• At week 24, 74% of icotrokinra-treated patients achieved IGA 0/1, and 65% reached PASI 90.
• Almost half of patients achieved completely clear skin (IGA 0) by Week 24.
• Adverse events were similar between icotrokinra and placebo groups, with no new safety signals.

Nearly half of patients with moderate-to-severe plaque psoriasis treated with icotrokinra achieved completely clear skin at week 24, according to new data presented at the 2025 America Academy of Derm...

• Exosomes, derived from human sources, exhibit significant variability depending on their origin and manufacturing process. Standardization remains critical for their widespread adoption in treatments.

• One nine-month study on a topical platelet-derived exosome serum revealed significant improveme...

At the 2025 American Academy of Dermatology (AAD) Annual Meeting, Saranya P. Wyles, MD, PhD, a dermatologist and researcher at the Mayo Clinic in Rochester, delivered an enlightening presentation on ...

Key Takeaways

1. Alopecia’s impact on a child’s mental and social well-being is profound, and accommodating their emotions and addressing psychosocial concerns is as crucial as treating the disease itself.
2. Treatments like JAK inhibitors, oral minoxidil, and dupilumab are viable treatment options in yo...

Understanding and treating pediatric alopecia areata (AA), and its impact on the emotional and social lives of children and young people, was the subject of a presentation by dermatologist Brittany Cr...